Posted by Michael Wonder on 31 May 2020
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3
28 May 2020 - As part of its coordinated response to the pandemic, the International Coalition of Medicines Regulatory Authorities convened its regular high-level meeting of regulators from around the world on 27 May 2020 to discuss COVID-19 policies, regulatory aspects of COVID-19 medicine development and pragmatic approaches to address challenges posed by the ongoing pandemic.
The coalition has established a COVID-19 Working Group to provide in-depth recommendations on priority topics in the context of COVID-19.
The main purpose of this working group is to draw on the expertise of regulatory authorities worldwide and assist the coalition in addressing concerns and issues raised during its strategic discussions on policies and regulatory flexibility.
